What policy changes should be on the next Prime Minister’s Agenda in order to re-vitalise the pharmaceutical industry in India? How can we as a country achieve the 3 As of healthcare: Affordability, Availability and Access? Express Pharma asks thought leaders to share their recommendations
– Shobha Mishra Ghosh, Sr Director, Federation of Indian Chambers of Commerce and Industry
– Ranjana Smetacek, Director General, Organisation of Pharmaceutical Producers of India
– DA Prasanna, Chairman, Association of Clinical Research Organizations
– Glenn Saldanha, Chairman & Managing Director Glenmark Pharmaceuticals
– Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon
– Ranjit Shahani, Vice Chairman & Managing Director, Novartis India
– Dr Arun Garg, General Secretary, Indian Pharmacy Graduates’ Association
– Sakthivel Selvaraj, Senior Health Economist, Public Health Foundation of India